PMID: 9421757Jan 1, 1997Paper

Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement

Journal of Biomedical Materials Research
I KhairounJ A Planell

Abstract

Clinical requirements for calcium phosphate bone cements were formulated in terms of the initial setting time, the final setting time, the cohesion time, and the ultimate compressive strength. Two cement formulations were tested. Biocement F was made of a powder containing alpha-tertiary calcium phosphate, precipitated hydroxyapatite, and monetite. Biocement D powder also contained CaCO3. The liquid/powder (L/P) ratio of the cement paste and the accelerator concentrations (% Na2HPO4) in the cement liquid were varied. For Biocement F there was a small area of combinations of L/P ratio and percent Na2HPO4 for which all clinical requirements were satisfied. This area covered only pastes that could be applied as doughs. However, Biocement D showed a much larger area of full compliance and it covered both doughlike and injectable pastes.

Citations

Sep 25, 1999·Journal of Biomedical Materials Research·E FernandezS M Best
May 10, 2002·Journal of Biomedical Materials Research·E M OomsJ A Jansen
Apr 12, 2002·Journal of Biomedical Materials Research·I KhairounP Weiss
Jul 25, 2009·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Thomas Lind-HansenMartin Lind
Nov 23, 2006·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Gianluca MaestrettiRoland Peter Jakob
Mar 18, 2009·Journal of Materials Science. Materials in Medicine·Dan KaiXingdong Zhang
Nov 16, 2013·Acta Biomaterialia·Jingtao ZhangJean-Michel Bouler
Jul 12, 2002·Biomaterials·R P del RealJ A Jansen
May 4, 2011·Tissue Engineering. Part C, Methods·Jan Willem M HoekstraJohn A Jansen
Nov 11, 2006·Journal of Biomaterials Science. Polymer Edition·W J E M HabrakenJ A Jansen
Feb 4, 2011·BMC Musculoskeletal Disorders·Esther M M Van LieshoutPeter Patka
Jan 21, 2016·Journal of Materials Science. Materials in Medicine·Jie AnSander C G Leeuwenburgh
Mar 14, 2003·Journal of Biomedical Materials Research. Part a·R P del RealJ A Jansen
Feb 9, 2012·Advanced Drug Delivery Reviews·Maria-Pau GinebraEdgar B Montufar
Aug 7, 2010·Acta Biomaterialia·Johan Van der StokPeter Patka
Jul 8, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Wouter J E M HabrakenJohn A Jansen
Apr 9, 2009·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Pei-Fu TangYan Wang
Jan 15, 2008·Journal of Biomedical Materials Research. Part a·W J E M HabrakenJ A Jansen
Jan 4, 2012·Journal of Biomedical Materials Research. Part a·Kemal SariibrahimogluJohn A Jansen
Sep 17, 2010·Journal of Biomedical Materials Research. Part a·Corina VaterMichael Gelinsky
Jun 7, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Ninette TödtmannUwe Eckelt
Mar 19, 2016·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jithendra T B RatnayakeGeorge J Dias
Aug 31, 2012·Journal of Tissue Engineering and Regenerative Medicine·Anja LodeMichael Gelinsky
Oct 15, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Mehri SohrabiAsghar Kazemzadeh
Feb 19, 2008·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Ronald MaiBernd Stadlinger
Apr 19, 2012·Journal of Tissue Engineering·Roman A PerezMaria-Pau Ginebra
Sep 25, 2017·Journal of Biomedical Materials Research. Part a·Irene Lodoso-TorrecillaJeroen J J P van den Beucken
Sep 16, 2004·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·U HempelK W Wenzel
Jul 2, 2003·Journal of Biomedical Materials Research. Part a·O GauthierP Weiss
May 6, 2004·Journal of Biomedical Materials Research. Part a·H SchliephakeS Scholz
Jul 20, 2007·Journal of Biomedical Materials Research. Part a·M Hamdan AlkhraisatE López-Cabarcos
Feb 12, 2008·Journal of Tissue Engineering and Regenerative Medicine·Adelina PlachokovaJohn Jansen
Apr 1, 2005·Journal of Biomedical Materials Research. Part a·Stefan RammeltAchim Biewener
Jul 7, 2010·Journal of Tissue Engineering and Regenerative Medicine·Liliana OfferReinhard Schnettler
Mar 7, 2019·Journal of Materials Science. Materials in Medicine·Song WangJianqiang Bi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.